Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for TIM 4
Most Correlated Studies
- Effect of TIM-3 stimulation on B16-F10 melanoma cells
- Effect of TIM-3 stimulation on IgE/antigen-activated mouse mast cells
- Tim-3 knockdown RAW264.7 monocyte cell line
- Acute erythroleukemia HEL cells treated with ruxolitinib, pevonedistat, or both
- Naive and inflammatory memory T cells from F5 TCR transgenic mice treated with IL-7 and IL-4
Most Relevant Literature
- Tim4 deficiency reduces CD301b+ macrophage and aggravates periodontitis bone loss.
- Tim-4 alleviates acute hepatic injury by modulating homeostasis and function of NKT cells.
- Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorig…
- T-cell immunoglobulin- and mucin-domain-containing molecule-4 maintains adipose tissue homeostasis b…
- Tim4 recognizes carbon nanotubes and mediates phagocytosis leading to granuloma formation.
Most Relevant Clinical Trials
- Cultural Adaptation of the TIM&SARA Prevention Program
- A Taiwan Isoflavone Multicenter Study (TIMS)
- Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis
- Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-T…
- A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participa…
